Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, NAT

Tower Surgical Partners Opens Outpatient Centers to All Surgeons Performing Urgent, Time-Sensitive Procedures During COVID-19 Pandemic


WASHINGTON, April 13, 2020 /PRNewswire/ -- In light of the COVID-19 crisis that has caused thousands of patients and hospitals to postpone surgeries indefinitely, Tower Surgical Partners, a leader in ambulatory surgical center (ASC) development and management, announced today that it has opened its ambulatory surgery centers, called ASCs, to all physicians practicing gynecology, urology, pain management and general surgery. The ASCs are located in Rockville, MD (Innovations Surgery Center and GYN SurgiCenter) and Secaucus, NJ (Center for Modern Surgery). This is a welcome option for surgeons who can now schedule their cases for symptomatic patients suffering from conditions requiring urgent surgical care.

This decision is supported by the U.S. Centers for Disease Control and Prevention's recommendation that some inpatient surgeries be shifted to outpatient settings. The Ambulatory Surgery Center Association also provided guidance that, during the COVID-19 pandemic, ASCs should continue to allow surgeries to be performed for patients whom physicians deem "urgent and necessary." As part of this effort, Tower Surgical Partners is facilitating an expedited physician credentialing process that will take under a week to give doctors the ability to perform surgeries at these surgical centers.

"With COVID-19 sweeping the country, Tower Surgical Partners (TSP) does not want patients who require urgent surgical procedures to continue suffering from severe bleeding, pain, and progressive conditions that may force them to a local emergency room for care," said Robert Lacava, ASC Operations Lead for TSP. "Access will be made available to physicians in specialties requiring urgent surgical care for their patients. By doing this, we are hoping to play our part in freeing up critical space in hospitals so that they can focus on treating COVID-19."

TSP is fully in line with the American College of Surgeons and the American Association of Gynecologic Laparoscopists' recommendation not to delay any surgical procedure that may lead to progressive morbidity or a worsening condition over time. Both societies have indicated that surgeons should consider transferring patients to an Ambulatory Surgery Center, when possible, to allow for urgent surgical procedures to be performed safely and effectively.

Advances in technology and laparoscopic techniques, as well as a shift in surgery from the inpatient to outpatient setting, has resulted in a migration of many surgical procedures to ASCs, which allow for same-day surgeries and patient discharge. Additionally, these specialized ASCs have the demonstrated advantages of greater efficiency, safety and patient convenience, along with a higher staff-to-patient ratio and lower costs compared with the hospital-based outpatient surgery model. Additionally, there is a much lower infection rate compared hospitals with large numbers of COVID-19 patients admitted. ASCs do not have inpatient services, and do not care for COVID-19 patients.

About Tower Surgical Partners
Formed in 2015, Tower Surgical Partners is a comprehensive ASC management company with experts in site development/acquisition, legal, finance, state accreditation, policies, and operations. For more information, visit https://towersurgicalpartners.com.

SOURCE Tower Surgical Partners


These press releases may also interest you

at 13:00
In an industry where success often hinges on the backing of major labels, Boston-born hip-hop artist and MIH Universal founder Matt Corman has defied the odds. Grossing over $1 million from digital streaming alone, Corman has risen to the top 1% of...

at 11:45
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...

at 11:30
NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico received a regulatory approval letter from the ethical, scientific, and safety committees of Hospital La Mision in Monterrey, Mexico, to launch a clinical...

at 11:00
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....

at 11:00
Art's Way Manufacturing Co., Inc. (the "Company"), a diversified manufacturer and distributor of equipment serving agricultural and research needs, announces its financial results for the second quarter of fiscal 2024 and six months ended...

at 10:35
The "Indonesia Construction Industry Databook Series - Market Size & Forecast by Value and Volume (area and units), Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. The construction industry in Indonesia is expected to...



News published on and distributed by: